Agios Reports Business Highlights and Second Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
Agios Pharma (AGIO) Tops Q2 EPS by 6c
July 30, 2020 7:46 AM EDTAgios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.31), $0.06 better than the analyst estimate of ($1.37). Revenue for the quarter came in at $37.35 million versus the consensus estimate of $37.71 million.
For earnings history and earnings-related data on Agios Pharma (AGIO) click here.
... More